By this point, substantial new collagen has been deposited, elastin fibers have increased, and extracellular matrix remodeling has progressed meaningfully
The inhibitory ability of the designed peptide (CAND) was then verified using FPA competition analysis to ensure its continued effectiveness in inhibiting the interaction between FOXO4 and p53 TAD (Figure
Full AI Image Prompt: Create a clinical safety infographic titled GHK-Cu Safety Considerations by Route. Use a three-column matrix labeled Topical products, Wound-care study context, and Injectable or compounded preparations. Under topical products, include skin irritation, allergic reaction, and formulation sensitivity. Under wound-care study context, include study exclusions, copper or peptide sensitivity, and dressings or adhesives. Under injectable or compounded preparations, include limited human safety data, peptide-related impurities, aggregation risk, and immunogenicity risk. Use a calm medical style, white background, simple icons, and subtle copper-blue accents
B) Calibration curve prepared using kinetic method